Alpine Immune Sciences, Inc.
ALPNDelisted May 20, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626199
Alpine Immune Sciences, Inc. was delisted on May 20, 2024; its insiders filed their last Form 4 on May 20, 2024; 180 institutions reported holding it in 13F filings for Q1 2024, worth $2.56B in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Alpine Immune Sciences, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 64 | 61 | −3 |
| Shares | 40.9M | 41.4M | +454.1K (+1.1%) |
| Value | $300.8M | $319.4M | +$18.6M (+6.2%) |
New holders (5)
Institutions that held Alpine Immune Sciences, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ghost Tree Capital, LLC | 200,000 | $1.54M | 0.58% |
| HighVista Strategies LLC | 90,287 | $697.0K | 0.57% |
| Walleye Capital LLC | 34,117 | $263.4K | 0.01% |
| SG Americas Securities, LLC | 11,927 | $92.0K | 0.00% |
| Wells Fargo & Company | 4,392 | $33.9K | 0.00% |
Sold out (8)
Institutions that held Alpine Immune Sciences, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Cheyne Capital Management (UK) LLP | 181,886 | $1.34M |
| Pura Vida Investments, LLC | 30,924 | $227.3K |
| Citadel Advisors LLC | 21,204 | $155.8K |
| Trexquant Investment LP | 16,763 | $123.2K |
| Allspring Global Investments Holdings, LLC | 4,453 | $32.7K |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 1,714 | $12.6K |
| Tradewinds Capital Management, LLC | 15 | $110 |
| Credit Suisse AG | 1 | $7 |